Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine hydrogel for pain after impacted mandibular wisdom tooth extraction
IRCT20221201056682N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Bupivacaine hydrogel with Placebo hydrogel (2 arms). Primary endpoints: Post-operative pain and Number of painkillers used. Started Sep 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20221201056682N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221201056682N1.